# Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

> **NCT04690348** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 103 (estimated)

## Conditions studied

- Recurrent Brain Metastases

## Interventions

- **PROCEDURE:** Craniotomy
- **RADIATION:** Cesium-131 brachytherapy

## Key facts

- **NCT ID:** NCT04690348
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-24
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690348, "Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04690348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*